Apogenix's Grant

Apogenix raised a round of funding on January 05, 2012. Investors include BMBF GOBio.

Apogenix, a spin-out from the German Cancer Research Center (DKFZ), is developing protein therapeutics for the treatment of cancer and inflammatory diseases based either on the targeted modulation of …

Articles about Apogenix's Grant: